Koninklijke Philips N.V. (NYSE:PHG) Given Average Recommendation of “Moderate Buy” by Brokerages

Koninklijke Philips N.V. (NYSE:PHGGet Free Report) has received an average rating of “Moderate Buy” from the five research firms that are presently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company.

Several equities analysts have recently issued reports on PHG shares. Wall Street Zen raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Royal Bank Of Canada started coverage on shares of Koninklijke Philips in a research report on Wednesday. They issued a “sector perform” rating on the stock. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Koninklijke Philips in a research report on Monday.

View Our Latest Stock Analysis on PHG

Koninklijke Philips Trading Down 1.0%

NYSE PHG traded down $0.27 during trading hours on Wednesday, hitting $26.26. 199,540 shares of the company’s stock were exchanged, compared to its average volume of 906,743. The firm has a market cap of $25.29 billion, a price-to-earnings ratio of 131.31, a PEG ratio of 0.71 and a beta of 0.79. The stock has a 50-day simple moving average of $27.81 and a 200 day simple moving average of $26.56. The company has a current ratio of 1.32, a quick ratio of 0.86 and a debt-to-equity ratio of 0.68. Koninklijke Philips has a 1-year low of $21.48 and a 1-year high of $29.54.

Koninklijke Philips (NYSE:PHGGet Free Report) last issued its earnings results on Tuesday, November 4th. The technology company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37. The business had revenue of $5.05 billion for the quarter, compared to analyst estimates of $4.30 billion. Koninklijke Philips had a net margin of 1.07% and a return on equity of 12.14%. On average, equities analysts forecast that Koninklijke Philips will post 1.63 EPS for the current fiscal year.

Hedge Funds Weigh In On Koninklijke Philips

Hedge funds have recently bought and sold shares of the company. First Affirmative Financial Network grew its position in Koninklijke Philips by 5.1% during the third quarter. First Affirmative Financial Network now owns 11,418 shares of the technology company’s stock valued at $311,000 after acquiring an additional 550 shares during the last quarter. Coldstream Capital Management Inc. purchased a new stake in shares of Koninklijke Philips in the 3rd quarter valued at $401,000. Morningstar Investment Management LLC bought a new position in shares of Koninklijke Philips during the 3rd quarter valued at $5,434,000. XTX Topco Ltd grew its holdings in shares of Koninklijke Philips by 6.2% during the 3rd quarter. XTX Topco Ltd now owns 31,246 shares of the technology company’s stock valued at $852,000 after purchasing an additional 1,825 shares during the last quarter. Finally, United Capital Financial Advisors LLC purchased a new position in Koninklijke Philips in the 3rd quarter worth $213,000. Hedge funds and other institutional investors own 13.67% of the company’s stock.

About Koninklijke Philips

(Get Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

Further Reading

Analyst Recommendations for Koninklijke Philips (NYSE:PHG)

Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.